Michel Arcand, MD
Orthopaedic Surgery · Johnston, RINPI 1699756791
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $42,003 of the $45,781 with a category attached, or 91.7%. Anika Therapeutics, Inc. accounts for 91.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $42,027 and has fallen 98.5% since, to $631 in 2025.
Across 15 payments — averaging $3052.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$42K
- Tigon Medical LLC$3K
- Arthrex$462
- Stryker$200
- Kairos Surgical Inc$98
- Johnson & Johnson$41
- plus $101 from 4 others
What the payments were for
- Consulting fees$2,8756%
- Travel & lodging$4381%
- Food & beverage$4641%
- Ownership interest$42,00392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 1 | $42,003 |
| Tigon Medical LLC | 2 | $2,875 |
| Arthrex | 2 | $462 |
| Stryker | 3 | $200 |
| Kairos Surgical Inc | 1 | $98 |
| Johnson & Johnson | 2 | $41 |
| Acumed LLC | 1 | $35 |
| Heron Therapeutics, Inc. | 1 | $29 |
| Acell, Inc. | 1 | $23 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INSPACE$140
How this compares
$45,781 in reported general payments places this provider in the 85th percentile of 124 orthopaedic surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 85 | $642 |
| Ibuprofen | 29 | $516 |
| Meloxicam | 85 | $405 |
| Amoxicillin | 44 | $40 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Johnston
- Anthony BuonannoJohnston$2M
- Alan DanielsEast Providence$1.9M
- Robert MarchandWakefield$1.4M
- Michael BradleyWakefield$1.4M
- Edward PaxtonProvidence$244K
- Valentin AntociEast Providence$210K
- Dominic KleinhenzEast Providence$164K
- Bassel DieboEast Providence$138K
- Steven BokshanProvidence$130K
- Ian MadomWakefield$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.